Cargando…

Immunoglobulin replacement therapy targeting the BCR in chronic lymphocytic leukemia

Detalles Bibliográficos
Autor principal: Ferrer, Gerardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197750/
https://www.ncbi.nlm.nih.gov/pubmed/30219356
http://dx.doi.org/10.1016/j.ebiom.2018.09.008
_version_ 1783364835548856320
author Ferrer, Gerardo
author_facet Ferrer, Gerardo
author_sort Ferrer, Gerardo
collection PubMed
description
format Online
Article
Text
id pubmed-6197750
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-61977502018-10-24 Immunoglobulin replacement therapy targeting the BCR in chronic lymphocytic leukemia Ferrer, Gerardo EBioMedicine Commentary Elsevier 2018-09-12 /pmc/articles/PMC6197750/ /pubmed/30219356 http://dx.doi.org/10.1016/j.ebiom.2018.09.008 Text en © 2018 The Author http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Commentary
Ferrer, Gerardo
Immunoglobulin replacement therapy targeting the BCR in chronic lymphocytic leukemia
title Immunoglobulin replacement therapy targeting the BCR in chronic lymphocytic leukemia
title_full Immunoglobulin replacement therapy targeting the BCR in chronic lymphocytic leukemia
title_fullStr Immunoglobulin replacement therapy targeting the BCR in chronic lymphocytic leukemia
title_full_unstemmed Immunoglobulin replacement therapy targeting the BCR in chronic lymphocytic leukemia
title_short Immunoglobulin replacement therapy targeting the BCR in chronic lymphocytic leukemia
title_sort immunoglobulin replacement therapy targeting the bcr in chronic lymphocytic leukemia
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197750/
https://www.ncbi.nlm.nih.gov/pubmed/30219356
http://dx.doi.org/10.1016/j.ebiom.2018.09.008
work_keys_str_mv AT ferrergerardo immunoglobulinreplacementtherapytargetingthebcrinchroniclymphocyticleukemia